Obesity Clinical Trials in New York, New York

26 studies are recruiting for obesity in New York, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

    This trial will examine if maridebart cafraglutide as an adjunct to standard of care will lead to a reduction in heart failure (HF) events such as HF hospitalizations and urgent HF visits, cardiovascular (CV) deaths and improvement in HF symptoms in participants with HF with preserved ejection frac…

    Stage
    Phase 3
    Ages
    18 to 99
    Site
    Icahn School of Medicine at Mount Sinai, New York, New York
    Locations
    657 in total
    Run by
    Amgen

    See if you can join NCT07037459 on ClinicalTrials.gov

  2. AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

    This study is being done to look at the efficacy and safety of NNC0487-0111 in participants with excess body weight and obstructive sleep apnoea not treated with positive airway pressure lose weight and improve sleep apnoea. There are 2 study treatments in this study taken as injections under the s…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Weil Cornell Medicine, New York, New York
    Locations
    80 in total
    Run by
    Novo Nordisk A/S

    See if you can join NCT07571005 on ClinicalTrials.gov

  3. AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

    This study is being done to look at the efficacy and safety of NNC0487-0111 in participants with overweight or obesity, and obstructive sleep apnoea treated with positive airway pressure. There are 2 study treatments in this study taken as injections under the skin once a week. Participants will ei…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Weil Cornell Medicine, New York, New York
    Locations
    92 in total
    Run by
    Novo Nordisk A/S

    See if you can join NCT07571109 on ClinicalTrials.gov

  4. Graded Insulin Suppression Test P&F

    The goal of this study is to learn about how the hormone insulin controls blood sugar in a variety of people. The main question it aims to answer is about how much insulin the body actually needs to maintain a normal blood sugar level. Participants will be asked to come in for a one-day study visit…

    Stage
    Phase 1
    Ages
    18 to 65
    Site
    Columbia University Irving Medical Center, New York, New York
    Run by
    Columbia University

    See if you can join NCT06592261 on ClinicalTrials.gov

  5. A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

    The main purpose of this study is to evaluate the efficacy and safety of eloralintide compared with placebo in participants with persistent obesity or overweight, with or without type 2 diabetes, and on stable incretin background therapy. Participation in the study will last about 80 weeks.

    Stage
    Phase 3
    Ages
    18 and older
    Site
    NYU Langone Health, New York, New York
    Locations
    187 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT07392190 on ClinicalTrials.gov

  6. A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

    The purpose of this clinical study is to learn about the effects and safety of berobenatide (PF-08653944). This may help people with overweight or obesity lose weight. People in this study may also have type 2 diabetes. About 950 adults will be in this study. Berobenatide will be compared to a plac…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Weill Cornell Medicine - Comprehensive Weight Control Center, New York, New York
    Locations
    50 in total
    Run by
    Pfizer

    See if you can join NCT07595549 on ClinicalTrials.gov

  7. Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)

    The researchers will conduct 'Taxi ROADmAP (Realizing Optimization Around Diet And Physical activity)', which also utilizes MOST, and the same 4 obesity intervention components as in SANOS, but targets the overweight/obesity crisis in another at-risk, low socioeconomic status (SES) population, taxi…

    Stage
    Phase 2
    Ages
    21 and older
    Site
    Mexican Consulate's Ventanilla de Salud (VDS), New York, New York
    Run by
    Memorial Sloan Kettering Cancer Center

    See if you can join NCT05770570 on ClinicalTrials.gov

  8. Incretin Therapies in Obesity-related HFpEF

    The central hypothesis to be tested is that patients with obesity and heart failure with preserved ejection fraction (HFpEF) prescribed tirzepatide will demonstrate reductions in measured plasma volume. In conjunction with state-of-the-art body composition analysis and measures of adipokines, this …

    Stage
    Phase 4
    Ages
    40 and older
    Site
    Columbia University Irving Medical Center (CUIMC) / NewYork Presbyterian Hospital (NYP), New York, New York
    Run by
    Columbia University

    See if you can join NCT07554638 on ClinicalTrials.gov

  9. A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

    This study is being done to look at the safety and effect of NNC0487-0111 in people with Heart Failure with preserved Ejection Fraction (HFpEF) or Heart Failure with mildly reduced Ejection Fraction (HFmrEF) and excess body weight when compared to placebo. The purpose of this clinical study is to f…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    NYU Langone Med Assoc Chelsea, New York, New York
    Locations
    838 in total
    Run by
    Novo Nordisk A/S

    See if you can join NCT07567001 on ClinicalTrials.gov

  10. AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

    This study is being done to look at the safety and effect of NNC0487-0111 in people with excess body weight and knee osteoarthritis when compared to placebo. There are 2 study treatments in this study taken as injections under the skin once a week. Participants will either get NNC0487-0111, (the tr…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Hospital For Special Surgery, New York, New York
    Locations
    81 in total
    Run by
    Novo Nordisk A/S

    See if you can join NCT07509307 on ClinicalTrials.gov

  11. AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

    The purpose of this clinical study is to find out if NNC0487-0111 is safe and effective for treating people who have excess body weight. There are 2 study treatments in this study taken as injections under the skin once a week. Participants will either get NNC0487-0111 (the treatment being tested) …

    Stage
    Phase 3
    Ages
    18 and older
    Site
    New York Gastroenterology Associates, New York, New York
    Locations
    72 in total
    Run by
    Novo Nordisk A/S

    See if you can join NCT07339423 on ClinicalTrials.gov

  12. Effect of Insulin Lowering on Lipogenesis

    The goal of this clinical trial is to compare a one-week course of diazoxide (2 mg/kg per dose x 14 doses) and placebo in people with obesity and insulin resistance (IR) with metabolic dysfunction-associated steatotic liver disease (MASLD). The main question it aims to answer are how mitigation of …

    Stage
    Phase 1
    Ages
    18 to 65
    Site
    Columbia University Irving Medical Center, New York, New York
    Run by
    Columbia University

    See if you can join NCT07403604 on ClinicalTrials.gov

  13. A Study to Investigate Why Overweight People Regain Weight After Losing Weight in a Behavioral Weight Loss Program

    The goal of this clinical trial is to determine the physiological basis for the differences in weight regain among adults (25-59 years old) with obesity following participation in a behavioral weight loss program. Eligible participants will undergo a baseline evaluation after which they will enter …

    Stage
    Not phased
    Ages
    25 to 59
    Site
    Columbia University Irving Medical Center, New York, New York
    Locations
    3 in total
    Run by
    University of Pittsburgh

    See if you can join NCT05748158 on ClinicalTrials.gov

  14. Weight Loss Study: Genetics and Response to Naltrexone/Bupropion

    The goal of this clinical trial is to understand if genetic variations are associated with the amount of weight loss with diet and while taking an FDA-approved medication for weight loss. The main question[s] it aims to answer are: * In Aim One, the investigators propose to rigorously test the hypo…

    Stage
    Phase 4
    Ages
    18 to 65
    Site
    Columbia University Medical Center, New York, New York
    Run by
    Columbia University

    See if you can join NCT05919797 on ClinicalTrials.gov

  15. Impact of Yo-Yo Sleep on Cardiometabolic Health

    The goal of this clinical trial is to test the impact of repeated intermittent short sleep, with short sleep maintained 5 days per week followed by 2 days of prolonged sleep, compared to daily adequate sleep, on energy balance and cardiometabolic risk. A secondary goal of this research is to determ…

    Stage
    Not phased
    Ages
    18 to 49
    Site
    Columbia University Irving Medical Center, New York, New York
    Run by
    Columbia University

    See if you can join NCT05880758 on ClinicalTrials.gov

  16. Endoscopic Bariatric Therapies (EBTs): A Retrospective and Prospective Multicenter Registry

    The purpose of this registry study is to collect data through medical chart review and in patient visits on the efficacy and safety of various Endoscopic Bariatric therapies (EBTs). This is a retrospective and prospective, observational, medical chart review study for at least 6 standard of care vi…

    Stage
    Not phased
    Ages
    18 to 89
    Site
    Weill Cornell Medicine, New York, New York
    Run by
    Weill Medical College of Cornell University

    See if you can join NCT04494048 on ClinicalTrials.gov

  17. A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use

    The goal of this study is to measure the effects of using Tradipitant to treat nausea and vomiting induced by GLP-1R agonist use in adults with class I or class II obesity, or adults who are overweight with at least one weight-related condition. The study is placebo-controlled with two treatment ar…

    Stage
    Phase 3
    Ages
    18 to 65
    Site
    Vanda Investigational Site, New York, New York
    Locations
    10 in total
    Run by
    Vanda Pharmaceuticals

    See if you can join NCT07446439 on ClinicalTrials.gov

  18. Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)

    The purpose of this study is to determine the most effective family-centered intervention (FCI) for weight loss and obesity prevention in Hispanic families. FCI is a type of program that involves family (such as parents and caregivers) supporting their children to promote healthy habits.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York
    Run by
    Memorial Sloan Kettering Cancer Center

    See if you can join NCT07144800 on ClinicalTrials.gov

  19. Reducing Obesity Using Social Ties Program

    This trial aims to test the feasibility and acceptability of addressing interpersonal barriers to weight-related behavior change. Specifically, the study will test if, by including up to two friends, family members, or co-workers in a lifestyle intervention for weight loss, the person enrolled in t…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Weill Cornell Medicine, New York, New York
    Run by
    Weill Medical College of Cornell University

    See if you can join NCT06335810 on ClinicalTrials.gov

  20. Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients

    evaluation of the EndoZip system procedure compared to the Apollo ESG procedure in obese patients.

    Stage
    Not phased
    Ages
    21 to 65
    Site
    Lenox Hill Hospital | Northwell Health, New York, New York
    Locations
    2 in total
    Run by
    Nitinotes Surgical Ltd.

    See if you can join NCT07090005 on ClinicalTrials.gov

  21. High Fructose Diet, the Gut Microbiome, and Metabolic Health

    Americans commonly consume excess amounts of dietary fructose. Added fructose has been shown to have an adverse impact on metabolic health, including increased insulin resistance and type 2 diabetes (T2D) risk. However, the mechanisms that link dietary fructose and metabolic health are poorly under…

    Stage
    Not phased
    Ages
    25 to 45
    Site
    Mount Sinai Morningside, New York, New York
    Run by
    Icahn School of Medicine at Mount Sinai

    See if you can join NCT06329544 on ClinicalTrials.gov

  22. Study to Investigate Genetic Causes of Severe Early Childhood Onset Obesity.

    This study aims to investigate genetic causes of early childhood obesity. The investigators will enroll children and adults with severe early onset obesity (BMI > 99th percentile) diagnosed prior to 6 years of age. The investigators will ask questions about the health and eating behavior of the par…

    Stage
    Not phased
    Ages
    Up to 80
    Site
    Columbia University Medical Center, New York, New York
    Locations
    2 in total
    Run by
    Columbia University

    See if you can join NCT01998750 on ClinicalTrials.gov

  23. A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors

    The purpose of this study is determine the effectiveness of a six-month virtually-delivered dietary education intervention (PEDALL) on the prevention of overweight and obesity (OW/OB) during maintenance chemotherapy in children and adolescents with acute lymphoblastic leukemia (ALL).

    Stage
    Not phased
    Ages
    5 to 21
    Site
    Columbia University Medical Center, New York, New York
    Run by
    Columbia University

    See if you can join NCT05963971 on ClinicalTrials.gov

  24. Circadian Misalignment and Energy Balance

    Preliminary findings from the investigators' lab suggest that circadian misalignment, occurring when meals and sleep are mistimed from one another, alters resting state neuronal processing in areas relevant to food reward and interoception; supporting a role of sleep and meal misalignment, on energ…

    Stage
    Not phased
    Ages
    20 to 49
    Site
    Columbia University Irving Medical Center, New York, New York
    Run by
    Columbia University

    See if you can join NCT03663530 on ClinicalTrials.gov

  25. Chronic Widespread Pain After Rapid Weight Loss in Non-Hispanic Black and Hispanic/Latino/a/x Adults

    The goal of this observational study is to learn if surgical weight loss can improve chronic widespread pain in people living with higher BMI who self-identify as Hispanic/Latino ethnicity or non-Hispanic Black based on the United States census racial categories. The main questions the study aims t…

    Stage
    Not phased
    Ages
    18 to 75
    Site
    NYU Steinhardt Arthur J. Nelson Laboratory, New York, New York
    Locations
    3 in total
    Run by
    New York University

    See if you can join NCT06795386 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.